Hurum Co., Ltd. (KOSDAQ:353190)
South Korea · Delayed Price · Currency is KRW 634.00
-12.00 (-1.86%)
At close: Mar 31, 2026
Hurum Revenue
In the year 2025, Hurum had annual revenue of 99.01B KRW with 0.86% growth. Hurum had revenue of 23.54B in the quarter ending December 31, 2025, with 18.29% growth.
Revenue
99.01B
Revenue Growth
+0.86%
P/S Ratio
0.25
Revenue / Employee
722.71M
Employees
137
Market Cap
24.97B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 99.01B | 845.62M | 0.86% |
| Dec 31, 2024 | 98.17B | 9.76B | 11.04% |
| Dec 31, 2023 | 88.41B | 21.50B | 32.13% |
| Dec 31, 2022 | 66.91B | -2.17B | -3.14% |
| Dec 31, 2021 | 69.08B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Korean Drug | 62.51B |
| ChoA Pharmaceutical Co., LTD. | 59.31B |
| WooGene B&G | 54.76B |
| Seoul Pharma | 52.15B |
| Kwangdong Healthbio | 38.10B |
| Union Korea Pharm | 33.83B |
| Daesung Microbiological Labs. | 25.99B |
| BIFIDO | 19.68B |